Mohamed Abazeed

  • 751 Citations
20002019
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Training Experience

2008Postdoctoral Fellowship, University of Michigan
2013Residency, Harvard Medical School

Education/Academic qualification

MD, PhD, University of Michigan

… → 2008

Fingerprint Dive into the research topics where Mohamed Abazeed is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

trans-Golgi Network Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Radiotherapy Medicine & Life Sciences
Endosomes Medicine & Life Sciences
Radiation Medicine & Life Sciences
Mutation Medicine & Life Sciences
Radiation Tolerance Medicine & Life Sciences
tumors Physics & Astronomy

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2000 2019

2 Citations (Scopus)

An image-based deep learning framework for individualising radiotherapy dose: a retrospective analysis of outcome prediction

Lou, B., Doken, S., Zhuang, T., Wingerter, D., Gidwani, M., Mistry, N., Ladic, L., Kamen, A. & Abazeed, M. E., Jul 2019, In : The Lancet Digital Health. 1, 3, p. e136-e147

Research output: Contribution to journalArticle

Open Access
Radiotherapy
Learning
Treatment Failure
Cohort Studies
Lung
1 Citation (Scopus)

Cellular and genetic determinants of the sensitivity of cancer to α-particle irradiation

Yard, B. D., Gopal, P., Bannik, K., Siemeister, G., Hagemann, U. B. & Abazeed, M. E., Nov 1 2019, In : Cancer Research. 79, 21, p. 5640-5651 12 p.

Research output: Contribution to journalArticle

Open Access
Neoplasms
Relative Biological Effectiveness
Radiation
Radium
Mutation

Clonal selection confers distinct evolutionary trajectories in BRAF-driven cancers

Gopal, P., Sarihan, E. I., Chie, E. K., Kuzmishin, G., Doken, S., Pennell, N. A., Raymond, D. P., Murthy, S. C., Ahmad, U., Raja, S., Almeida, F., Sethi, S., Gildea, T. R., Peacock, C. D., Adams, D. J. & Abazeed, M. E., Dec 1 2019, In : Nature communications. 10, 1, 5143.

Research output: Contribution to journalArticle

Open Access
mutations
Tumors
tumors
cancer
Trajectories

Distinct clinical and biological implications of CUX1 in myeloid neoplasms

Aly, M., Ramdzan, Z. M., Nagata, Y., Balasubramanian, S. K., Hosono, N., Makishima, H., Visconte, V., Kuzmanovic, T., Adema, V., Nazha, A., Przychodzen, B. P., Kerr, C. M., Sekeres, M. A., Abazeed, M. E., Nepveu, A. & Maciejewski, J. P., Jul 23 2019, In : Blood Advances. 3, 14, p. 2164-2178 15 p.

Research output: Contribution to journalArticle

Open Access
Homeobox Genes
Myelodysplastic Syndromes
Neoplasms
Acute Myeloid Leukemia
Exome
3 Citations (Scopus)

Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model

Matossian, M. D., Burks, H. E., Elliott, S., Hoang, V. T., Bowles, A. C., Sabol, R. A., Wahba, B., Anbalagan, M., Rowan, B., Abazeed, M. E., Bunnell, B. A., Moroz, K., Miele, L., Rhodes, L. V., Jones, S. D., Martin, E. C., Collins-Burow, B. M. & Burow, M. E., Mar 7 2019, In : BMC cancer. 19, 1, 205.

Research output: Contribution to journalArticle

Open Access
Triple Negative Breast Neoplasms
Drug Resistance
Heterografts
Pharmaceutical Preparations
Neoplastic Stem Cells